Terumo Europe’s Post

Did you know contents in the Investigator Brochure. The IB is a critical tool in clinical research, ensuring that investigators have all the necessary information to conduct the trial ethically and safely. It helps investigators understand the scientific rationale, the potential benefits, and the risks associated with the investigational product. This comprehensive document supports informed decision-making and safeguards the well-being of trial participants. Satish Marukurthi Jacob Odika Apollo

SETAC Fort Worth abstracts are due WEDNESDAY MAY 15 or May 22 with a rush fee! Please consider the below session where Alan J. Jones, Ph.D. and I want to provide a forum for all of those pain points, uncertainties, scientific conundrums, and frustrations that come up when designing, executing and submitting ecotoxicology data packages to regulatory agencies. While many aspects of these processes are laid out explicitly and governed by official guidelines/guidances, those of us who work in this area known there are a endless intricacies and caveats to actually executing. We are looking for submissions from regulated industries, regulators, CROs, consultants, and anybody else who works in this space!

The use of estimands in clinical trial protocols is growing following the release of new regulatory guidance. Learn more in this new white paper from our experts.

PN Update: LifeGlobal Media - Procedural steps and scientific information after initial consultation

Thanks to Claudia and Alexa and all co-authors for the Nice collaboration on this important paper on Scientific Advice in EU! The regulatory framework of the European Union (EU) offers multiple and valuable options for SA. At a time of increasing scientific complexity and global competition, navigating the SA landscape may be challenging. This article provides an overview of these challenges and reflects on the ways in which the already available SA options could be consolidated and optimized for building an integrated, easy-to-navigate process. At a Time of reflection on the legislative framework, it is key to consider avoiding dispertion of the scientific knowledge, creating continuum from early research to registration.

Use the link in the Bio on Instagram to see the entire review! Link: https://ow.ly/c3me50SxNG4 "After one month of practicing Qigong, significant immunological changes were observed, highlighting its potential impact on the immune system." Manzaneque, J. M., Vera, F. M., Maldonado, E. F., Carranque, G., Cubero, V. M., Morell, M., & Blanca, M. J. (2004). Assessment of immunological parameters following a qigong training program. Medical Science Monitor, 10(6), CR264-CR270.

Beatrice S. is the Chief Scientific Officer of Altasciences, Her guidance, Altasciences has swiftly adapted, recognizing the unique attributes of psychedelic compounds, and developing safe and efficient clinical methods for their study in the early phases. Read More: https://cutt.ly/seT7uEV2 #DrugDevelopment #PharmaceuticalInnovation #DrugDiscovery #HealthcareAdvancements #MedicalResearch #PharmaLeaders #InsightsCare #healthcareinnovationmagazines

🧠 Curious minds, get ready to expand your knowledge and address misconceptions. #NoJargon is back! This time, we asked our scientists to explain what a vaccine adjuvant is. Let's improve your scientific knowledge with Greg Troiano, Lorena Preciado Llanes and Vincent PAVOT 👇

In the European Union, a device is considered equivalent if it fulfills all the requirements of technical, clinical, and biological equivalence. Of these, demonstrating biological equivalence tends to be the toughest aspect of the overall equivalence argument. Read more about this topic in our latest blog post: https://hubs.ly/Q02LXPLQ0